{"address1": "645 Summer Street", "address2": "Suite 101", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "857 273 8343", "website": "https://ikenaoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ikena Oncology, Inc. operates as an oncology company in the United States. The company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. The company develops IK-595, a molecular glue which is in Phase 1 clinical trial to trap MEK and RAF in an inactive complex. Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark  Manfredi Ph.D.", "age": 52, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 868194, "exercisedValue": 0, "unexercisedValue": 46699}, {"maxAge": 1, "name": "Dr. Jotin  Marango M.D., Ph.D.", "age": 44, "title": "COO, CFO, Head of Corporate Development & Treasurer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 809946, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rebecca  Cohen", "title": "Vice President of Investor Relations, Corporate Strategy & Communication", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  Ecsedy Ph.D.", "age": 54, "title": "Chief Development Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bob  Lally", "title": "Senior Vice President of Finance & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Damphousse M.S.", "title": "Senior Vice President of Clinical Development Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Valdas  Jurkauskas Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.28, "open": 1.28, "dayLow": 1.19, "dayHigh": 1.3, "regularMarketPreviousClose": 1.28, "regularMarketOpen": 1.28, "regularMarketDayLow": 1.19, "regularMarketDayHigh": 1.3, "payoutRatio": 0.0, "beta": 0.496, "forwardPE": -1.4705882, "volume": 106340, "regularMarketVolume": 106340, "averageVolume": 125918, "averageVolume10days": 62940, "averageDailyVolume10Day": 62940, "bid": 1.19, "ask": 1.26, "bidSize": 1, "askSize": 1, "marketCap": 60322624, "fiftyTwoWeekLow": 1.19, "fiftyTwoWeekHigh": 1.94, "fiftyDayAverage": 1.4034, "twoHundredDayAverage": 1.609475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -56542360, "profitMargins": 0.0, "floatShares": 7895027, "sharesOutstanding": 48258100, "sharesShort": 151688, "sharesShortPriorMonth": 154141, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0031, "heldPercentInsiders": 0.045450002, "heldPercentInstitutions": 0.87755996, "shortRatio": 1.87, "shortPercentOfFloat": 0.0034999999, "impliedSharesOutstanding": 48258100, "bookValue": 2.61, "priceToBook": 0.47892722, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -49234000, "trailingEps": -1.02, "forwardEps": -0.85, "enterpriseToEbitda": 1.046, "52WeekChange": -0.0636704, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.25, "targetHighPrice": 4.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.0, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 124386000, "totalCashPerShare": 2.578, "ebitda": -54064000, "totalDebt": 7521000, "quickRatio": 11.541, "currentRatio": 11.799, "debtToEquity": 5.972, "returnOnAssets": -0.20441, "returnOnEquity": -0.33301, "grossProfits": -30875000, "freeCashflow": -31550250, "operatingCashflow": -46004000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IKNA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Ikena Oncology, Inc.", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NGM", "messageBoardId": "finmb_302325481", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Ikena Oncology, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616765400000, "regularMarketChange": -0.029999971, "regularMarketDayRange": "1.19 - 1.3", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 125918, "fiftyTwoWeekLowChange": 0.059999943, "fiftyTwoWeekLowChangePercent": 0.050420117, "fiftyTwoWeekRange": "1.19 - 1.94", "fiftyTwoWeekHighChange": -0.69000006, "fiftyTwoWeekHighChangePercent": -0.35567012, "fiftyTwoWeekChangePercent": -6.3670397, "earningsTimestamp": 1741267800, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.02, "epsForward": -0.85, "epsCurrentYear": -0.53, "priceEpsCurrentYear": -2.3584907, "fiftyDayAverageChange": -0.15339994, "fiftyDayAverageChangePercent": -0.10930593, "twoHundredDayAverageChange": -0.35947502, "twoHundredDayAverageChangePercent": -0.22334924, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-26", "cryptoTradeable": false, "regularMarketChangePercent": -2.3437479, "regularMarketPrice": 1.25, "marketState": "PRE", "displayName": "Ikena Oncology", "trailingPegRatio": null}